Contrast nephropathy: Are short-term outcome measures adequate for quantification of long-term renal risk?

Research output: Contribution to journalComment/debate

10 Scopus citations


This Practice Point commentary discusses the findings of a prospective observational study by Weisbord et al. that attempted to quantify the incidence and outcomes of contrast-induced acute kidney injury in patients with stage 3 chronic kidney disease (CKD). These data are set in the context of recent observations linking acute kidney injury with the progression of CKD to end-stage renal disease. The commentary also asks whether standard short-term clinical outcome measures - i.e. changes in serum creatinine - are adequate to assess the risk of disease progression in patients with mild-to-moderate CKD.

Original languageEnglish (US)
Pages (from-to)594-595
Number of pages2
JournalNature Clinical Practice Nephrology
Issue number11
StatePublished - Nov 1 2008



  • Acute kidney injury
  • Chronic kidney disease
  • Contrast nephropathy
  • Outcome measures
  • Serum creatinine

ASJC Scopus subject areas

  • Nephrology

Cite this